Sedana Medical AB announces that all 235 randomized patients have been recruited for its INSPiRE-ICU 2 phase III clinical trial in the United States.
Sedana Medical AB announces that all 235 randomized patients have been recruited for its INSPiRE-ICU 2 phase III clinical trial in the United States.